The WACC of Pharmala Biotech Holdings Inc (MDMA.CN) is 10.3%.
| Range | Selected | |
| Cost of equity | 15.10% - 18.50% | 16.80% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 9.4% - 11.1% | 10.3% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 2.35 | 2.35 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 15.10% | 18.50% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 9.4% | 11.1% |
| Selected WACC | 10.3% | |